Come up with a name for your new list and we'll add to it:
Ensysce Biosciences raised a round of funding on June 17, 2010. Investors include
Texas Emerging Technology Fund.
Ensysce Biosciences is focused on the use of fullerene carbon nanotubes for therapeutic applications specifically in the area of cancer treatment. The company's extensive carbon nanotube-related, worl…